Predicting Phenolic Acid Absorption in Caco-2 Cells: A Theoretical Permeability Model and Mechanistic Study

被引:37
作者
Farrell, Tracy L. [1 ]
Poquet, Laure [3 ]
Dew, Tristan P. [1 ]
Barber, Stuart [2 ]
Williamson, Gary [1 ,3 ]
机构
[1] Univ Leeds, Sch Food Sci & Nutr, Leeds, W Yorkshire, England
[2] Univ Leeds, Dept Stat, Leeds LS2 9JT, W Yorkshire, England
[3] Nestle Res Ctr, CH-1000 Lausanne, Switzerland
关键词
ORAL-DRUG ABSORPTION; IN-VITRO; P-GLYCOPROTEIN; INTESTINAL-ABSORPTION; CHLOROGENIC ACIDS; MOLECULAR-WEIGHT; TRANSPORT; MONOLAYERS; HUMANS; DIFFUSION;
D O I
10.1124/dmd.111.041665
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
There is a considerable need to rationalize the membrane permeability and mechanism of transport for potential nutraceuticals. The aim of this investigation was to develop a theoretical permeability equation, based on a reported descriptive absorption model, enabling calculation of the transcellular component of absorption across Caco-2 monolayers. Published data for Caco-2 permeability of 30 drugs transported by the transcellular route were correlated with the descriptors 1-octanol/water distribution coefficient (log D, pH 7.4) and size, based on molecular mass. Nonlinear regression analysis was used to derive a set of model parameters a', beta', and b' with an integrated molecular mass function. The new theoretical transcellular permeability (TTP) model obtained a good fit of the published data (R-2 = 0.93) and predicted reasonably well (R-2 = 0.86) the experimental apparent permeability coefficient (P-app) for nine non-training set compounds reportedly transported by the transcellular route. For the first time, the TTP model was used to predict the absorption characteristics of six phenolic acids, and this original investigation was supported by in vitro Caco-2 cell mechanistic studies, which suggested that deviation of the P-app value from the predicted transcellular permeability (P-app(trans)) may be attributed to involvement of active uptake, efflux transporters, or paracellular flux.
引用
收藏
页码:397 / 406
页数:10
相关论文
共 41 条
[1]
Development of a 7-day, 96-well Caco-2 permeability assay with high-throughput direct UV compound analysis [J].
Alsenz, J ;
Haenel, E .
PHARMACEUTICAL RESEARCH, 2003, 20 (12) :1961-1969
[2]
CORRELATION BETWEEN ORAL-DRUG ABSORPTION IN HUMANS AND APPARENT DRUG PERMEABILITY COEFFICIENTS IN HUMAN INTESTINAL EPITHELIAL (CACO-2) CELLS [J].
ARTURSSON, P ;
KARLSSON, J .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 175 (03) :880-885
[3]
Caco-2 monolayers in experimental and theoretical predictions of drug transport (Reprinted from Advanced Drug Delivery Reviews, vol 22, pg 67-84, 1996) [J].
Artursson, P ;
Palm, K ;
Luthman, K .
ADVANCED DRUG DELIVERY REVIEWS, 2001, 46 (1-3) :27-43
[4]
How Well Can the Caco-2/Madin-Darby Canine Kidney Models Predict Effective Human Jejunal Permeability? [J].
Avdeef, Alex ;
Tam, Kin Y. .
JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (09) :3566-3584
[5]
PHYSICAL AND CHEMICAL-PROPERTIES OF DRUG MOLECULES GOVERNING THEIR DIFFUSION THROUGH THE SPINAL MENINGES [J].
BERNARDS, CM ;
HILL, HF .
ANESTHESIOLOGY, 1992, 77 (04) :750-756
[6]
Estimation of permeability by passive diffusion through Caco-2 cell monolayers using the drugs' lipophilicity and molecular weight [J].
Camenisch, G ;
Alsenz, J ;
van de Waterbeemd, H ;
Folkers, G .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 1998, 6 (04) :313-319
[7]
Characterization of hydroxycinnamic acid glucuronide and sulfate conjugates by HPLC-DAD-MS2: Enhancing chromatographic quantification and application in Caco-2 cell metabolism [J].
Farrell, Tracy ;
Poquet, Laure ;
Dionisi, Fabiola ;
Barron, Denis ;
Williamson, Gary .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2011, 55 (05) :1245-1254
[8]
Fraga S, 2006, FASEB J, V20, pA841
[9]
In vitro models for the blood-brain barrier [J].
Garberg, P ;
Ball, M ;
Borg, N ;
Cecchelli, R ;
Fenart, L ;
Hurst, RD ;
Lindmark, T ;
Mabondzo, A ;
Nilsson, JE ;
Raub, TJ ;
Stanimirovic, D ;
Terasaki, T ;
Öberg, JO ;
Österberg, T .
TOXICOLOGY IN VITRO, 2005, 19 (03) :299-334
[10]
Direct demonstration of small intestinal secretion and site-dependent absorption of the beta-blocker talinolol in humans [J].
Gramatte, T ;
Oertel, R ;
Terhaag, B ;
Kirch, W .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1996, 59 (05) :541-549